Why do you say that? Seems to me like all the defunct tickers gone now OTC is set up for some huge runners in 2022 and beyond. Of course the market wont just reward companies for keeping current - theyll need ti bring accretive deals to the table in order to attract buyers... maybe CUBV will show how its done.